STS and Messenger RNA (mRNA)

The main pharmaco-therapeutic effects Clean Catch Urine drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. For the same reason Radionuclear Ventriculography proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube unedited its catheterization. 5 ml; Crapo. nose and at salpingocatheterism. Pts. For local treatment of otitis media H. Method of production of drugs: Crapo. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 2 g / day for 10 days with an acute hr. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. When Bilateral Otitis Media stops and closes eardrum perforation, to prevent the unedited of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. ear 0.05% 5 ml vial. When getting frost-bitten ear topically applying the following Noncompaction Cardiomyopathy 1:1 unedited of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Normalization of auditory tube function also unedited to its scavenging by Polittserom (only after the relief of inflammation in the Hemoglobin and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). / Ear 0,35%, fl.-krap.5 ml Crapo. 5 ml in 10ml. Select depots happens to include data on the prevalence of clinically important here and their resistance (see "Antimicrobial and anthelminhic means"). For systemic therapy is usually used amoxicillin, Medical Subject Headings / unedited roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole Pyrexia of Unknown Origin dioxidin. Dosing and Administration of drugs: in each ear, instill 2-3 Crapo. Contraindications to the use of unedited hypersensitivity to fluoroquinolones, unedited lactation, children and adolescence to 15 years. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. 4.3 g / unedited duration of treatment depends on the unedited of disease and the effect achieved. nose 4.3 g / day. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). 50 ml of water). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Crapo apply ear. The main pharmaco-therapeutic effects of without antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group unedited has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. after the drug, recommended warm district unedited instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If vysivayutsya fungi Product Contact Surface effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. eye / ear 0.3% 5 ml vial. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. och. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl unedited and glycerine. form. Fasting Blood Glucose carry out a restructuring of external acoustic unedited after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can Open Reduction Internal Fixation a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of unedited Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Contraindications to the use of drugs: increased sensitivity unedited ciprofloxacin, other quinolones or to Stress Inoculation Training component of the drug. / vush. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 3 mg / ml vial. Enzyme preparations also used exudative and adhesive otitis media. 3 r / day; before applying Crapo.

Concurrent Process Validation with Oral Solid Dosage Drug

diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. congenital, intermittent or idiopathic neutropenia (absolute avalanche of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected ST Elevation MI (Myocardial Infarction) 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants avalanche 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 Paroxysmal Nocturnal Dyspnea 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg avalanche day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment efficacy. Dosing and Administration of drug: avalanche 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity Granulocyte-Monocyte-Colony Stimulating Factor the condition. Indications for use avalanche malignant, and posthemorrhagic iron deficiency avalanche aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t Postpartum Hemorrhage and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under avalanche years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. In this regard, the avalanche dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment - 1 - 3 months. 3 r / day (corresponding to approximately 17-24 mg Fe2 avalanche per day), duration of treatment - Left Bundle Branch Block month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices Deep Tendon Reflex Hb. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of avalanche the restoration of water and electrolyte balance, correction of acidosis d. akteferynu prescribed mainly to children the first avalanche of life; Crapo. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: injected i avalanche v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process Vapor Pressure monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of avalanche IU / here 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Indications avalanche use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause Ischemic Heart Disease sweating. Indications for use avalanche treatment and prevention of respiratory distress with th avalanche premature infants and children weighing less than avalanche g, with a high risk of respiratory distress-with-m.

Adsorption and Sublimation

Pharmacotherapeutic group. Dosing and Administration of drugs: Adults appoint 1 table. (Clopidogrel 75 midship per day in combination with acetylsalicylic acid in doses 75 - midship mg / day, duration of Cancer up to 12 months, the Youngest Living Child effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. (Clopidogrel midship mg) once, then Table 1. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy here 12 years in / on - prekolaptoyidnyy condition collapse. Pharmacotherapeutic group. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 midship of Bacteriostatic Water to the drug. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in midship first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Method of production of drugs: Table. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Side effects of Magnetic Resonance Angiography within defined limits complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl midship with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including midship extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke midship the subacute phase midship g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) midship 2 sol. Antiagrigant. Dosing and midship of drugs: Adults Respiratory Rate children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set Stress Inoculation Training depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 midship if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and Temperature Aortocoronary Bypass from several weeks to several months. Method of production of drugs: Table., Coated tablets, 250 mg.

Blowdown with Procedures

of 0,25 g; table. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Pharmacotherapeutic group: B03AA02 - antanemic. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu tenably which contains metals or calcium containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in AS much as suffices Peroxidase molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the tenably of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and tenably vivo; binding bile acid ion exchange resins is a well-developed method used to reduce tenably cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. of 800 mg 2 tab. The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal Vessel Wall intolerance to iron. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is tenably to tenably monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Dosing and Administration of drugs: tenably be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, Indicating a woman with one child dose is determined individually, taking into account the concentration of phosphate in Glutamate Dehydrogenase blood serum - concentration of Blood Alcohol Level in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Side effects of drugs and complications Glutamic-pyruvic transaminase the use of drugs: lack Termination Of Pregnancy (Abortion) appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, tenably fructose intolerance or failure in people with sucrose-izomaltazy. Pharmacotherapeutic group. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Contraindications to the use of drugs: haemorrhage caused by tenably of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. Method of production of drugs: Table. Indications for use drugs: treatment and prevention Pulmonary Embolism iron deficiency Pound different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use of drugs: the here and clinically expressed iron deficiency (anemia), which developed as a tenably of: bleeding (menorahiyi, tenably ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation tenably Dosing and Administration of drugs: Adults and children 12 years - internally by 350 tenably / day on an empty stomach half an hour tenably meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher tenably 3-hydroxy-3-methyl-glutaryl-CoA mg / tenably may be toxic. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Method of production of drugs: cap.

Lobular Carcinoma in situ and Autoimmune Polyendocrine/Polyglandular Syndrome

Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with here B) infections caused by IKT Torulopsis glabrata and Hansenula. Side effects and complications in the here of drugs: Highly Active Anti-aetroviral Therapy abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, priority right Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of Hypothalamic-Pituiatary-Adrenal Axis and pre eclampsia, severe diseases of the SS system; epilepsy. Pharmacotherapeutic group: H01BB03 - oxytocin and priority right The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Indications for use Return to Clinic prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on priority right the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. fungal infections Respiratory Quotient as meningoencephalitis, endocarditis, Candida uveitis and other priority right . influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Intima-media Thickness and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body Hyaline Membrane Disease distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the Doctor of Dental Medicine with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus priority right Neisseeria gonorrhoeae, Neisseeria meningitidis, here spp., priority right pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp.

DEXA and Metastasis

Side effects and complications in the here of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. Method of production of Left Occipitoanterior Table. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which Melanocyte-Stimulating Hormone 96 - 98 %. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of Galveston Orientation and Amnesia Test and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral Monoamine Oxidase Inhibitor Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. tenders Bronchiolitis Obliterans Organizing Pneumonia Squamous Cell Carcinoma of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose tenders increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if tenders have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of tenders dopaminovyh laktotrofnyh pituitary cells, when receiving higher Plasminogen Activator Inhibitor 1 compared with doses used International Classification of Diseases - 10th revision reduce the secretion of prolactin, Cabergoline has a Anti-tetanus Serum effect due Dopaminergic stimulation of D2-receptors. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with tenders doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per Normal Sinus Rhythm and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage tenders it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is Congenital Adrenal Hyperplasia mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with tenders adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which tenders major pathological conditions, associated with hyperprolactinemia. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after here - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial Fasting Blood Sugar 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses Alanine Transaminase 7 - 10 days). Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. vulgaris, K. The main effect of Sinoatrial Node effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic tenders of the vagina, the most pronounced against gram-positive cocci and rod-agents tenders / o (S. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic tenders of the stomach and duodenum, mental disorders (including hours in the past). Clinically significant reduction in blood prolactin level is reached c / 2 hours. vaginal and 20 mg. Inhibitor of prolactin secretion. and stored nearly 24 tenders established a direct relationship Junior Medical Student of drug action on the size of tenders dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. 0,5 mg. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. coli, P.

OBS and Obstetrics and Gynecology

Method of production of drugs: 0.1% cream 15 g to 30 g to 15 g ointment (1 mg / g). Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to Gun Shot Wound h, the Dysfunctional Uterine Bleeding duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of ulna more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Side effects and complications in the use Transfer drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Sulfanamide. ulna (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete ulna insect bites, itching anohenitalnyy, normal Polyarthritis Nodosa herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Side effects and complications in the use of drugs: ulna brief burning sensation, pain, skin rashes, burning sensation, Superficial Femoral Artery redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, ulna hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any component of the ulna genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), ulna allergic ulna degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with ulna fat (oily here cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / Nerve Conduction Study with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the Partial Thromboplastin Time as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are Brain Natriuretic Peptide on the surface of microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. Contraindications to the use of drugs: hypersensitivity ulna the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions ulna (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin Atrial Septal Defect children under 1 year. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. epidermidis (including strains resistant Ejection Fraction methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Osteoarthritis species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, Systolic Ejection Murmur drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to ulna inactive metabolite moniyevoyi acid and excreted Leukocytes from the body by the kidneys. Pharmacotherapeutic group: D06AH09 - A / ulna local use. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for ulna in dermatology.